Key Market Indicators
Senegal aims to boost its vaccination coverage to 95% of children aged one by 2028, up from 92% in 2023. This growth reflects an average annual increase of 0.4 percentage points. Since 1991, the country has seen a steady rise in vaccination rates, averaging a 2.3 percentage point increase year on year. However, the outlook for Senegalese vaccine exports is less optimistic. By 2028, exports are expected to decline to approximately $788,000, down from $993,000 in 2023, marking an average annual decrease of 3.8%. Since 2002, vaccine exports have fallen by 18% annually. In 2023, Senegal ranked 40th in vaccine exports, with Latvia surpassing it at a similar export value. Belgium, the United Kingdom, and France held the second, third, and fourth positions, respectively. On the import side, Senegal is projected to see significant growth. Vaccine imports are set to reach nearly $12.5 million by 2028, up from $10 million in 2023. This represents a compound annual growth rate (CAGR) of 3.3%. Since 2001, the country's demand for vaccines has surged by 32.4% annually.
